HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape-Reference-Cited by-同舟云学术

HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape

Published:2014-11-25 Issue:2 Volume:6 Page:886-901
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Conte Mariarosaria¹,Dell’Aversana Carmela²,Benedetti Rosaria¹,Petraglia Francesca¹,Carissimo Annamaria¹,Petrizzi Valeria Belsito³,Maria D’Arco Alfonso³,Abbondanza Ciro¹,Nebbioso Angela¹,Altucci Lucia¹²

Affiliation:

1. Department of Biochemistry, Biophysics and General Pathology, Seconda Università degli Studi di Napoli, vico L. De Crecchio, Naples, IT

2. Institute of Genetics and Biophysics, IGB ‘Adriano Buzzati-Traverso’, Via P. Castellino, Naples, IT

3. Division of Onco-Hematology, Umberto I Hospital, via S. Francesco, Nocera Inferiore (SA), IT

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing HCC Treatment: innovatively combining HDAC2 inhibitor with PD-1/PD-L1 inhibition;Cancer Cell International;2023-09-16

2. Targeting HDAC2-Mediated Immune Regulation to Overcome Therapeutic Resistance in Mutant Colorectal Cancer;Cancers;2023-03-24

3. Histone deacetylases (HDACs) as the promising immunotherapeutic targets for hematologic cancer treatment;European Journal of Medicinal Chemistry;2023-01

4. Balancing Histone Deacetylase (HDAC) Inhibition and Drug‐likeness: Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors;ChemMedChem;2022-02-18

5. 4-Acyl Pyrrole Capped HDAC Inhibitors: A New Scaffold for Hybrid Inhibitors of BET Proteins and Histone Deacetylases as Antileukemia Drug Leads;Journal of Medicinal Chemistry;2021-09-28